NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3077% above fair value
$12.02−0.50 (-3.99%)
Close on Nov 12, 2026Market cap $412.58MP/E –Yield 0.00%
NeuroPace ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for NeuroPace
NeuroPace has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?